BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18825403)

  • 21. Recent development of nanoparticles for molecular imaging.
    Kim J; Lee N; Hyeon T
    Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gold nanoparticles as contrast agents in x-ray imaging and computed tomography.
    Cole LE; Ross RD; Tilley JM; Vargo-Gogola T; Roeder RK
    Nanomedicine (Lond); 2015 Jan; 10(2):321-41. PubMed ID: 25600973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-biofouling conducting polymer nanoparticles as a label-free optical contrast agent for high resolution subsurface biomedical imaging.
    Au KM; Lu Z; Matcher SJ; Armes SP
    Biomaterials; 2013 Nov; 34(35):8925-40. PubMed ID: 23968854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents.
    Nordmeyer D; Stumpf P; Gröger D; Hofmann A; Enders S; Riese SB; Dernedde J; Taupitz M; Rauch U; Haag R; Rühl E; Graf C
    Nanoscale; 2014 Aug; 6(16):9646-54. PubMed ID: 24991655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications.
    Liu Y; Ai K; Lu L
    Acc Chem Res; 2012 Oct; 45(10):1817-27. PubMed ID: 22950890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbubble embedded with upconversion nanoparticles as a bimodal contrast agent for fluorescence and ultrasound imaging.
    Jin B; Lin M; Zong Y; Wan M; Xu F; Duan Z; Lu T
    Nanotechnology; 2015 Aug; 26(34):345601. PubMed ID: 26243035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
    Chen YC; Chang WH; Wang SJ; Hsieh WY
    J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging.
    Rhyner MN; Smith AM; Gao X; Mao H; Yang L; Nie S
    Nanomedicine (Lond); 2006 Aug; 1(2):209-17. PubMed ID: 17716110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gd-containing conjugated polymer nanoparticles: bimodal nanoparticles for fluorescence and MRI imaging.
    Hashim Z; Green M; Chung PH; Suhling K; Protti A; Phinikaridou A; Botnar R; Khanbeigi RA; Thanou M; Dailey LA; Commander NJ; Rowland C; Scott J; Jenner D
    Nanoscale; 2014 Jul; 6(14):8376-86. PubMed ID: 24941427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in 4D medical imaging and 4D radiation therapy.
    Li G; Citrin D; Camphausen K; Mueller B; Burman C; Mychalczak B; Miller RW; Song Y
    Technol Cancer Res Treat; 2008 Feb; 7(1):67-81. PubMed ID: 18198927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
    Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
    J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imaging.
    Rosenberger I; Schmithals C; Vandooren J; Bianchessi S; Milani P; Locatelli E; Israel LL; Hübner F; Matteoli M; Lellouche JP; Franchini MC; Passoni L; Scanziani E; Opdenakker G; Piiper A; Kreuter J
    J Control Release; 2014 Nov; 194():130-7. PubMed ID: 25173842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theranostic Nanoparticles for Tracking and Monitoring Disease State.
    Zavaleta C; Ho D; Chung EJ
    SLAS Technol; 2018 Jun; 23(3):281-293. PubMed ID: 29115174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive imaging of transplanted cells.
    Modo M
    Curr Opin Organ Transplant; 2008 Dec; 13(6):654-8. PubMed ID: 19060558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.
    Ehlerding EB; Grodzinski P; Cai W; Liu CH
    ACS Nano; 2018 Mar; 12(3):2106-2121. PubMed ID: 29462554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphiphilic polymer-coated hybrid nanoparticles as CT/MRI dual contrast agents.
    Kim D; Yu MK; Lee TS; Park JJ; Jeong YY; Jon S
    Nanotechnology; 2011 Apr; 22(15):155101. PubMed ID: 21389582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional nanoparticles for use in theranostic applications.
    Cole JT; Holland NB
    Drug Deliv Transl Res; 2015 Jun; 5(3):295-309. PubMed ID: 25787729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of the art in vivo imaging techniques for laboratory animals.
    Lauber DT; Fülöp A; Kovács T; Szigeti K; Máthé D; Szijártó A
    Lab Anim; 2017 Oct; 51(5):465-478. PubMed ID: 28948893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical imaging of the diabetic foot.
    Loredo RA; Garcia G; Chhaya S
    Clin Podiatr Med Surg; 2007 Jul; 24(3):397-424, viii. PubMed ID: 17613383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.